How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: The "forgotten adjunct therapy": the link between ESA use and control of hyperparathyroidism in chronic kidney disease.
作者信息
Battistella Marisa, Chan Christopher T
机构信息
From Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
出版信息
Semin Dial. 2013 Sep-Oct;26(5):537-40. doi: 10.1111/sdi.12106. Epub 2013 Jun 5.
PMID:23734745
Abstract
摘要
Zotero 插件